BridgeMD
New treatment option for First Episode Psychosis (FEP)
Official title Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
ClinicalTrials.gov ID: NCT06650943
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate if a nursing intervention based on the carbohydrate-insulin model can effectively reduce weight and manage the risk of metabolic syndrome (MetS) in individuals with first-episode psychosis. The main questions it aims to answer are: Will the intervention lead to a clinically significant weight loss (≥5%)?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients admitted to the Early Intervention Program (EIP).
- First-episode psychosis (FEP) within the last 5 years.
- Diagnosis of psychosis from the F2 spectrum or an affective disorder with psychotic symptoms according to ICD-10.
You likely can't join if
- Cognitive inability to learn or comorbid intellectual disability that interferes with study procedures.
- Comorbid diagnosis of neurological pathology.
- Language or comprehension impairments preventing accurate data collection.
- Use of hypoglycemic medication before or during the study.
- Refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- Bilbao, Vizcaya, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bilbao, Vizcaya, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.